Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on BCAL Diagnostics.
RELATED STOCKHEAD STORIES
News
ASX Small Caps Lunch Wrap: Who else has been left running for their lives this week?
News
Rise and Shine: Everything you need to know before the ASX opens
News
Closing Bell: RBA pause positivity short lived as ASX 200 has worst day in four weeks
News
In Case You Missed It: Breast cancer test success and new scanner tech launched in US lottery tickets
News
ASX Small Caps Lunch Wrap: Who else wouldn’t be dead for quids today?
Health & Biotech
ASX Health Stocks: PYC granted FDA Fast Track; BCAL announces breakthrough results
News
Top 10 at 10: AW1 makes big copper find in Canada; Breast cancer diagnostics test gets a lift
News
Market Highlights: The US stripped of AAA rating; Bitcoin now less volatile than stocks and gold
Health & Biotech
ASX Health Stocks: Resonance gets green light in US
News
ASX Small Cap Lunch Wrap: Who’s getting another fright this morning?
Health & Biotech
ASX Health Stocks: Paradigm rockets 21pc after getting FDA nod, Memphasys up 31pc on imminent launch
Health & Biotech
Dr Boreham’s Crucible: Is the end of painful biopsies in BCal Diagnostics’ blood?
News
Closing Bell: ASX closes the week 1.4pc higher, led by uranium
Health & Biotech
ASX Health Stocks: Neuroscientific pockets $25m R&D incentive, MGC Pharma jumps 15% on India approval for COVID-19 drug
Health & Biotech
Dr Boreham’s Crucible: Who’s winning and losing in the life sciences IPO Olympiad?
IPO Watch
IPO Watch: Property tech company Openn Negotiation surges 55pc on debut
IPO Watch
